Cited 2 times in
Multiple milia formation induced by dovitinib
DC Field | Value | Language |
---|---|---|
dc.contributor.author | 김도영 | - |
dc.date.accessioned | 2016-02-04T11:42:46Z | - |
dc.date.available | 2016-02-04T11:42:46Z | - |
dc.date.issued | 2015 | - |
dc.identifier.issn | 0385-2407 | - |
dc.identifier.uri | https://ir.ymlib.yonsei.ac.kr/handle/22282913/141031 | - |
dc.description.abstract | Dovitinib is a novel multi-target tyrosine kinase inhibitor that inhibits vascular endothelial growth factor receptor-1-3, platelet-derived growth factor receptor-β, Fms-like tyrosine kinase 3, c-Kit and fibroblast growth factor receptor-1-3. This compound is currently being assessed clinically for treatment of various malignancies. In phase I and II clinical trials of dovitinib treatment for renal cell carcinoma, 20% of patients experienced cutaneous adverse events, although the specific type of skin rash was not documented. Here, we report two cases of multiple milia formation induced by dovitinib. We believe our cases are the first report mainly showing non-inflammatory cystic structure. | - |
dc.description.statementOfResponsibility | open | - |
dc.format.extent | 411~413 | - |
dc.relation.isPartOf | JOURNAL OF DERMATOLOGY | - |
dc.rights | CC BY-NC-ND 2.0 KR | - |
dc.rights.uri | https://creativecommons.org/licenses/by-nc-nd/2.0/kr/ | - |
dc.subject.MESH | Aged | - |
dc.subject.MESH | Antineoplastic Agents/adverse effects | - |
dc.subject.MESH | Benzimidazoles/adverse effects* | - |
dc.subject.MESH | Female | - |
dc.subject.MESH | Humans | - |
dc.subject.MESH | Keratosis/chemically induced* | - |
dc.subject.MESH | Keratosis/pathology | - |
dc.subject.MESH | Male | - |
dc.subject.MESH | Middle Aged | - |
dc.subject.MESH | Protein Kinase Inhibitors/adverse effects | - |
dc.subject.MESH | Quinolones/adverse effects* | - |
dc.title | Multiple milia formation induced by dovitinib | - |
dc.type | Article | - |
dc.contributor.college | College of Medicine (의과대학) | - |
dc.contributor.department | Dept. of Dermatology (피부과학) | - |
dc.contributor.googleauthor | Dongyun Shin | - |
dc.contributor.googleauthor | Jimyung Seo | - |
dc.contributor.googleauthor | Soo Min Kim | - |
dc.contributor.googleauthor | Do Young Kim | - |
dc.identifier.doi | 10.1111/1346-8138.12799 | - |
dc.admin.author | false | - |
dc.admin.mapping | false | - |
dc.contributor.localId | A00384 | - |
dc.relation.journalcode | J01372 | - |
dc.identifier.eissn | 1346-8138 | - |
dc.identifier.pmid | 25683141 | - |
dc.identifier.url | http://onlinelibrary.wiley.com/doi/10.1111/1346-8138.12799/abstract | - |
dc.subject.keyword | anticancer drug side-effects | - |
dc.subject.keyword | cutaneous side-effects | - |
dc.subject.keyword | dovitinib | - |
dc.subject.keyword | milia | - |
dc.subject.keyword | milium | - |
dc.contributor.alternativeName | Kim, Do Young | - |
dc.contributor.affiliatedAuthor | Kim, Do Young | - |
dc.rights.accessRights | not free | - |
dc.citation.volume | 42 | - |
dc.citation.number | 4 | - |
dc.citation.startPage | 411 | - |
dc.citation.endPage | 413 | - |
dc.identifier.bibliographicCitation | JOURNAL OF DERMATOLOGY, Vol.42(4) : 411-413, 2015 | - |
dc.identifier.rimsid | 30467 | - |
dc.type.rims | ART | - |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.